Literature DB >> 27587530

Does laminar flow ventilation reduce the rate of infection? an observational study of trauma in England.

E M Pinder1, A Bottle2, P Aylin2, M D Loeffler1.   

Abstract

AIMS: To determine whether there is any difference in infection rate at 90 days between trauma operations performed in laminar flow and plenum ventilation, and whether infection risk is altered following the installation of laminar flow (LF). PATIENTS AND METHODS: We assessed the impact of plenum ventilation (PV) and LF on the rate of infection for patients undergoing orthopaedic trauma operations. All NHS hospitals in England with a trauma theatre(s) were contacted to identify the ventilation system which was used between April 2008 and March 2013 in the following categories: always LF, never LF, installed LF during study period (subdivided: before, during and after installation) and unknown. For each operation, age, gender, comorbidity, socio-economic deprivation, number of previous trauma operations and surgical site infection within 90 days (SSI90) were extracted from England's national hospital administrative Hospital Episode Statistics database. Crude and adjusted odds ratios (OR) were used to compare ventilation groups using hierarchical logistic regression. Subanalysis was performed for hip hemiarthroplasties.
RESULTS: A total of 803 065 trauma operations were performed during this time; 19 hospitals installed LF, 124 already had LF, 13 had PV and the type of ventilation was unknown in 28. Patient characteristics were similar between the groups. The rate of SSI90 was similar for always LF and PV (2.7% and 2.4%). For hemiarthroplasties of the hip, the rates of SSI90 were significantly higher for LF compared with PV (3.8% and 2.6%, OR 1.45, p = 0·001). Hospitals installing LF did not see any statistically significant change in the rate of SSI90.
CONCLUSION: The results of this observational study imply that infection rate is similar when orthopaedic trauma surgery is performed in LF and PV, and is unchanged by installing LF in a previously PV theatre. Cite this article: Bone Joint J 2016;98-B:1262-9. ©2016 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Infection; Joint replacement; Laminar flow; Orthopaedic trauma; Plenum ventilation

Mesh:

Year:  2016        PMID: 27587530     DOI: 10.1302/0301-620X.98B9.37184

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  4 in total

1.  Hip fracture surgery in mixed-use emergency theatres: is the infection risk increased? A retrospective matched cohort study.

Authors:  S K Agarwal; A A Khan; M Solan; M Lemon
Journal:  Ann R Coll Surg Engl       Date:  2017-10-19       Impact factor: 1.891

2.  Forced-Air Warming and Resistive Heating Devices. Updated Perspectives on Safety and Surgical Site Infections.

Authors:  Wiebke Ackermann; Qianqian Fan; Akarsh J Parekh; Nicoleta Stoicea; John Ryan; Sergio D Bergese
Journal:  Front Surg       Date:  2018-11-21

3.  Prevention of Surgical Site Infections in Neonates and Children: Non-Pharmacological Measures of Prevention.

Authors:  Aniello Meoli; Lorenzo Ciavola; Sofia Rahman; Marco Masetti; Tommaso Toschetti; Riccardo Morini; Giulia Dal Canto; Cinzia Auriti; Caterina Caminiti; Elio Castagnola; Giorgio Conti; Daniele Donà; Luisa Galli; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Nicola Petrosillo; Alessandro Simonini; Elisabetta Venturini; Fabio Caramelli; Gaetano Domenico Gargiulo; Enrico Sesenna; Rossella Sgarzani; Claudio Vicini; Mino Zucchelli; Fabio Mosca; Annamaria Staiano; Nicola Principi; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-06-27

4.  Better Operating Room Ventilation as Determined by a Novel Ventilation Index is Associated With Lower Rates of Surgical Site Infections.

Authors:  Bernard Surial; Andrew Atkinson; Rüdiger Külpmann; Arnold Brunner; Kurt Hildebrand; Benoît Sicre; Nicolas Troillet; Andreas Widmer; Eveline Rolli; Judith Maag; Jonas Marschall
Journal:  Ann Surg       Date:  2022-08-10       Impact factor: 13.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.